Publications
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS2023 | Publication without faculty affiliation
- Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides2022 | Publication without faculty affiliation
- Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents2022 | Publication without faculty affiliation
- Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-D-Aspartate receptors2021 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University, Faculty of Science
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- 7-phenoxytacrine is a dually acting drug with neuroprotective efficacy in vivo2021 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study2021 | Faculty of Pharmacy in Hradec Králové
Loading network view...